Skip to main content
. 2003 Nov 25;89(11):2078–2086. doi: 10.1038/sj.bjc.6601296

Table 4. Odds ratios (ORs) and 95% confidence intervals (CIs) for adenocarcinomas and squamous cell carcinomas of the cervix in relation to smoking.

  Adenocarcinoma
Squamous cell carcinoma
Squamous vs adenocarcinoma
  Cases/controls ORa 95% CI Cases/controls ORb 95% CI Squamous/adeno cases ORc 95% CI
Smoking status                  
 Never 72/394 1.00   121/394 1.00   121/72 1.00  
 Ever 108/529 0.80 0.56–1.13 270/529 1.05 0.79–1.40 270/108 1.50 0.99–2.27
 Past 32/181 0.75 0.46–1.20 60/181 0.70 0.47–1.03 60/32 1.05 0.60–1.85
 Current 76/348 0.82 0.56–1.21 210/348 1.26 0.93–1.71 210/76 1.74 1.11–2.71
                   
Age started smoking                  
 Never 72/394 1.00   121/394 1.00   121/72 1.00  
 10–16 years 60/300 0.71 0.47–1.08 165/300 1.07 0.77–1.47 165/60 1.68 1.04–2.72
 17+ years 48/229 0.91 0.59–1.38 105/229 1.04 0.74–1.47 105/48 1.31 0.80–2.16
Heterogeneity between groups within ever smokers     P=0.1     P=0.8     P=0.06
                   
Total duration for current smokers                  
 Never/<1 month 72/394 1.00   121/394 1.00   121/72 1.00  
 ⩽10 years 8/43 0.85 0.34–2.12 22/43 0.69 0.35–1.37 22/8 1.08 0.40–2.91
 10–20 years 37/192 0.72 0.44–1.18 116/192 1.13 0.79–1.62 116/37 1.66 0.96–2.85
 20+ years 31/113 0.80 0.46–1.39 72/113 2.05 1.29–3.26 72/31 2.44 1.26–4.72
Trend within current smokers     P=0.3     P=0.05     P=0.04
                   
Intensity (cigarettes per day) for current smokers                  
 Never 72/394 1.00   121/394 1.00   121/72 1.00  
 <15 39/194 0.72 0.45–1.15 109/194 1.28 0.90–1.82 109/39 1.92 1.13–3.25
 15+ 37/154 0.82 0.51–1.34 101/154 1.26 0.86–1.83 101/37 1.68 0.97–2.92
Heterogeneity between groups within current smokers     P=0.8     P=0.8     P=0.9

ORa, odds ratio for adenocarcinoma vs controls; ORb, odds ratio for squamous cell carcinoma vs controls; ORc, odds ratio for squamous cell carcinoma cases vs adenocarcinoma cases; all adjusted for age, region, total number of sexual partners, age at first intercourse, duration of oral contraceptive use, number of negative screening results and education.